Crisugabalin provides significant improvement in average daily pain score and shows promise as a postherpetic neuralgia treatment.

Grünenthal announced today that its U.S. subsidiary, Averitas Pharma, Inc., has completed recruitment for the Phase III clinical trial AV001. The trial investigates the efficacy, safety and ...

Averitas Pharma, the US subsidiary of Grünenthal, has completed patient recruitment for the Phase III AV001 clinical study, ...

Gabapentinoids -- pregabalin and gabapentin -- were tied to increased hip fracture risk in older adults. Gabapentinoids -- ...

Citation: Study shows long-term, low-dose antiviral treatment benefits patients with eye disease and pain from shingles (2024, October 19) retrieved 13 November 2024 from https://medicalxpress.com ...

The Phase III trial AV001 aims to evaluate QUTENZA in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures ...

Many Brits might unknowingly be walking a knife’s edge with their health, as an expert warned if left untreated, the disease ...

Long-term, low-dose antiviral treatment reduces the risk for potentially vision-damaging bouts of inflammation and infection, as well as pain, which occur when shingles affects the eye, according ...

Many Brits could be unknowingly teetering on the brink of serious health issues, as a leading expert warns that if left ...

Your mother unfortunately developed a complication of shingles called postherpetic neuralgia (PHN). The pain varies from ...